[HTML][HTML] ROCK inhibition in models of neurodegeneration and its potential for clinical translation

JC Koch, L Tatenhorst, AE Roser, KA Saal… - Pharmacology & …, 2018 - Elsevier
Neurodegenerative disorders like Parkinson's disease, Alzheimer's disease, or amyotrophic
lateral sclerosis are affecting a rapidly increasing population worldwide. While common …

Axonal regeneration: underlying molecular mechanisms and potential therapeutic targets

R Akram, H Anwar, MS Javed, A Rasul, A Imran… - Biomedicines, 2022 - mdpi.com
Axons in the peripheral nervous system have the ability to repair themselves after damage,
whereas axons in the central nervous system are unable to do so. A common and important …

Axon growth inhibition by RhoA/ROCK in the central nervous system

Y Fujita, T Yamashita - Frontiers in neuroscience, 2014 - frontiersin.org
Rho kinase (ROCK) is a serine/threonine kinase and a downstream target of the small
GTPase Rho. The RhoA/ROCK pathway is associated with various neuronal functions such …

Growth cone travel in space and time: the cellular ensemble of cytoskeleton, adhesion, and membrane

EA Vitriol, JQ Zheng - Neuron, 2012 - cell.com
Growth cones, found at the tip of axonal projections, are the sensory and motile organelles
of developing neurons that enable axon pathfinding and target recognition for precise wiring …

ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS

JC Koch, L Tönges, E Barski, U Michel, M Bähr… - Cell death & …, 2014 - nature.com
Abstract The Rho/ROCK/LIMK pathway is central for the mediation of repulsive
environmental signals in the central nervous system. Several studies using pharmacological …

Rho-kinase: regulation,(dys) function, and inhibition

E Amin, BN Dubey, SC Zhang, L Gremer… - Biological …, 2013 - degruyter.com
In a variety of normal and pathological cell types, Rho-kinases I and II (ROCKI/II) play a
pivotal role in the organization of the nonmuscle and smooth muscle cytoskeleton and …

Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease

L Tatenhorst, K Eckermann, V Dambeck… - Acta neuropathologica …, 2016 - Springer
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, yet
disease-modifying treatments do not currently exist. Rho-associated protein kinase (ROCK) …

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease

L Tönges, T Frank, L Tatenhorst, KA Saal, JC Koch… - Brain, 2012 - academic.oup.com
Axonal degeneration is one of the earliest features of Parkinson's disease pathology, which
is followed by neuronal death in the substantia nigra and other parts of the brain. Inhibition …

Axonal degeneration as a therapeutic target in the CNS

P Lingor, JC Koch, L Tönges, M Bähr - Cell and tissue research, 2012 - Springer
Degeneration of the axon is an important step in the pathomechanism of traumatic,
inflammatory and degenerative neurological diseases. Increasing evidence suggests that …

Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis

L Tönges, R Günther, M Suhr, J Jansen, A Balck… - Glia, 2014 - Wiley Online Library
Disease progression in amyotrophic lateral sclerosis (ALS) is characterized by degeneration
of motoneurons (MN) and their axons, but is also influenced by neighboring cells such as …